Coronary heart disease risk reduction in postmenopausal women: the role of statin therapy and hormone replacement therapy

Preventive Cardiology
Michael Clearfield

Abstract

The incidence of coronary heart disease in women rises sharply in the years following menopause, and prescribing of hormone replacement therapy in the belief that it might compensate for the loss of estrogen-mediated cardioprotection is widespread. However, controlled trials have failed to show a beneficial effect of hormone replacement therapy on the incidence of coronary events, and recent evidence suggests that hormone replacement therapy may even have a deleterious effect on primary coronary heart disease prevention. Statins are recommended as first-line treatment for lowering low-density lipoprotein cholesterol levels in women and are extremely valuable in reducing coronary heart disease risk in this group. An awareness of the benefits of appropriate statin treatment, and evidence showing that they can be safely added to hormone replacement therapy prescribed for the relief of menopausal symptoms and osteoporosis, provides the opportunity to optimize clinical outcomes for coronary heart disease among the large and expanding population of postmenopausal women.

References

Aug 1, 1978·Annals of Internal Medicine·T GordonP M McNamara
Oct 1, 1976·Annals of Internal Medicine·W B KannelT Gordon
Jan 4, 1993·Atherosclerosis·J C StevensonI F Godsland
Mar 6, 1997·The New England Journal of Medicine·K K KohR O Cannon
Aug 28, 1997·The New England Journal of Medicine·G M DarlingS R Davis
Jun 11, 1999·The New England Journal of Medicine·M E Mendelsohn, R H Karas
Apr 12, 2000·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·V De MitrioO Schiraldi
Aug 24, 2000·The New England Journal of Medicine·D M HerringtonD Waters
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Feb 20, 2002·JAMA : the Journal of the American Medical Association·Elizabeth Barrett-ConnorUNKNOWN MORE Investigators (Multiple Outcomes of Raloxifene Evaluation)
Jul 2, 2002·JAMA : the Journal of the American Medical Association·Deborah GradyUNKNOWN HERS Research Group
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Aug 21, 2002·Annals of Internal Medicine·Linda L HumphreyHarold C Sox
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Heidi D NelsonJanet D Allan
Sep 5, 2002·International Journal of Health Services : Planning, Administration, Evaluation·Eeva Ollila, Meri Koivusalo
Sep 24, 2002·International Journal of Cardiology·James K Liao
Sep 25, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·S C ClarkeP M Schofiel
Jul 16, 2003·The American Journal of Cardiology·Peter H JonesUNKNOWN STELLAR Study Group
Aug 9, 2003·The New England Journal of Medicine·JoAnn E MansonUNKNOWN Women's Health Initiative Investigators
Aug 9, 2003·The New England Journal of Medicine·Howard N HodisUNKNOWN Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group
Feb 6, 2004·Circulation·Lori MoscaUNKNOWN American Heart Association

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Primatology
Thomas B Clarkson, Margaret H Mehaffey
Trends in Endocrinology and Metabolism : TEM
Stefan StörkMichiel L Bots
Frontiers in Physiology
Susana NovellaCarlos Hermenegildo
© 2022 Meta ULC. All rights reserved